Who owns TANDEM DIABETES CARE INC?
- CUSIP Number: 875372ad6
Tip: Access positions for across all investors
Analyze quarterly positions in Tandem Diabetes Care with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tandem Diabetes Care stock
Who bought or sold TANDEM DIABETES CARE INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 100M | $87M | 150% | Sep 2025 |
|
| Linden Advisors | 64M | $56M | -32% | Sep 2025 |
|
| Bank Of Montreal | 42M | $41M | 100% | Jun 2025 |
|
| Advent Capital Management | 17M | $15M | -39% | Sep 2025 |
|
| Camden Asset Management | 14M | $12B | 0% | Sep 2025 |
|
| OZ Management | 9.8M | $8.6M | 0% | Sep 2025 |
|
| Calamos Advisors | 8.6M | $7.5M | -37% | Sep 2025 |
|
| Shenkman Capital Management | 7.5M | $6.7B | 2% | Sep 2025 |
|
| Walleye Trading Advisors | 5.0M | $4.4M | 150% | Sep 2025 |
|
| Morgan Stanley | 3.9M | $3.8M | 100% | Jun 2025 |
|
| FMR | 3.8M | $3.3M | -3% | Sep 2025 |
|
| Capstone Investment Advisors | 3.7M | $3.2M | -40% | Sep 2025 |
|
| Leucadia National Corporation | 3.4M | $3.0M | 275% | Sep 2025 |
|
| BlackRock | 3.2M | $2.8M | 0% | Sep 2025 |
|
| New York State Common Retirement Fund | 2.7M | $2.3M | -33% | Sep 2025 |
|
| CSS | 2.0M | $1.7M | 100% | Sep 2025 |
|
| Jump Financial | 1.0M | $874k | 100% | Sep 2025 |
|
| Palisade Capital Management | 500k | $436k | 0% | Sep 2025 |
|
| Barclays | 462k | $403k | -77% | Sep 2025 |
|
| Bank of New York Mellon | 200k | $174k | 0% | Sep 2025 |
|
| Context Capital Management | 31k | $27M | 47% | Sep 2025 |
|
| Insigneo Advisory Services | 11k | $9.6k | 0% | Sep 2025 |
|
Who sold out of Tandem Diabetes Care?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Lazard Asset Management | Jun 2025 | 15M | $14M |
| Bnp Paribas Arbitrage, Snc | Jun 2025 | 9.7M | $9.3M |
| Jain Global | Jun 2025 | 1.5M | $1.4M |
| Jpmorgan Chase & Co | Mar 2025 | 1.3M | $1.3M |
| Kohlberg Kravis Roberts & Co | Jun 2025 | 322k | $311M |